MARKET

HROW

HROW

Harrow Health Inc
NASDAQ
35.15
-1.20
-3.30%
After Hours: 35.15 0 0.00% 19:59 03/09 EDT
OPEN
35.63
PREV CLOSE
36.35
HIGH
35.95
LOW
33.74
VOLUME
1.78M
TURNOVER
--
52 WEEK HIGH
54.85
52 WEEK LOW
20.85
MARKET CAP
1.31B
P/E (TTM)
-251.4306
1D
5D
1M
3M
1Y
5Y
1D
Harrow Health Projects Robust Growth After Strong 2025
TipRanks · 2h ago
Weekly Report: what happened at HROW last week (0302-0306)?
Weekly Report · 17h ago
What Moved Markets This Week
Seeking Alpha · 2d ago
Major Harrow Health Stakeholder Makes a Bold Move on Wall Street
TipRanks · 4d ago
These Analysts Revise Their Forecasts On Harrow Following Q4 Results
Benzinga · 5d ago
Harrow price target lowered to $60 from $70 at Lake Street
TipRanks · 5d ago
Harrow price target lowered to $91 from $94 at Cantor Fitzgerald
TipRanks · 5d ago
Harrow Is Maintained at Overweight by Cantor Fitzgerald
Dow Jones · 5d ago
More
About HROW
Harrow, Inc. is a provider of ophthalmic disease management solutions. It offers a portfolio of products that address conditions affecting both the front and back of the eye, such as dry eye disease, wet age-related macular degeneration, cataracts, refractive errors, glaucoma and a range of other ocular surface conditions and retina diseases. It owns commercial rights to portfolios of branded ophthalmic pharmaceutical products in North America, all of which are marketed under the Harrow name. It owns and operates ImprimisRx, an ophthalmology-focused pharmaceutical-compounding business. It owns United States commercial rights to various products: IHEEZO, VEVYE, TRIESENCE, VIGAMOX, ILEVRO, FLAREX, NATACYN, ZERVIATE, BYQLOVI and others. Its product candidates include MELT-210, MELT-300 and MELT-400. VIGAMOX (moxifloxacin hydrochloride ophthalmic solution) 0.5%, a fluoroquinolone antibiotic eye drops for the treatment of bacterial conjunctivitis caused by susceptible strains of organisms.

Webull offers Harrow Inc stock information, including NASDAQ: HROW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HROW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading HROW stock methods without spending real money on the virtual paper trading platform.